Preoperative survivin, ERCC1, and PTEN expression in stage III non-small cell lung cancer (NSCLC) patients (pts) treated with neoadjuvant and definitive chemoradiation and association with overall survival (OS)

被引：0
|
作者：
Batus, Marta [1 ]
Fidler, Mary J. [1 ]
Walters, Kelly Kaiser [1 ]
Pool, Mark [1 ]
Mahon, Brett [1 ]
Basu, Sanjib [1 ]
Borgia, Jeffrey Allen [1 ]
Sher, David [1 ]
Bonomi, Philip D. [1 ]
机构：
[1] Rush Univ, Med Ctr, Chicago, IL 60612 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7067
引用
收藏
页数：1
相关论文
共 50 条
  • [41] THE VALUE OF CLINICAL TRIAL RESEARCH FOR ERCC1 TESTING IN STAGE I NON-SMALL CELL LUNG CANCER (NSCLC)
    Roth, Joshua A.
    Carlson, Josh J.
    Steuten, Lotte
    Ramsey, Scott D.
    Veenstra, David L.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S398 - S399
  • [42] Significance of survivin expression: Prognostic value and survival in stage III non-small cell lung cancer
    Wang, Meng
    Liu, Bao-Gang
    Yang, Zhao-Yang
    Hong, Xuan
    Chen, Gong-Yan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 3 (06) : 983 - 988
  • [43] Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients
    Ryu, J
    Park, S
    Kwak, S
    Hong, Y
    Kim, J
    Cho, J
    Lee, H
    LUNG CANCER, 2005, 49 : S376 - S376
  • [44] Association of EGFR Activating Mutations With Low ERCC1 Gene Expression in Non-small Cell Lung Cancer (NSCLC): Assessment of 1,207 Patients
    Gandara, D.
    Grimminger, P.
    Mack, P. C.
    Lara, P. N.
    Li, T.
    Danenberg, P. V.
    Danenberg, K.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S516 - S517
  • [45] Serum VEGF Associated With Survival in Non-Small Cell Lung Cancer Patients Treated With Definitive Chemoradiation Therapy
    Xu, T.
    Gomez, D.
    O'Reilly, M.
    Nguyen, Q.
    Levy, L. B.
    Komaki, R.
    Mohan, R.
    Liao, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S105 - S105
  • [46] Expression of ERCC1 and its clinicopathological correlations in non-small cell lung cancer
    Tepeli, Emre
    Caner, Vildan
    Buyukpinarbasili, Nur
    Cetin, G. Ozan
    Duzcan, Fusun
    Elmas, Levent
    Bagci, Gulseren
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (01) : 335 - 341
  • [47] Expression of ERCC1 and its clinicopathological correlations in non-small cell lung cancer
    Emre Tepeli
    Vildan Caner
    Nur Büyükpınarbaşılı
    G. Ozan Çetin
    Füsun Düzcan
    Levent Elmas
    Gülseren Bağcı
    Molecular Biology Reports, 2012, 39 : 335 - 341
  • [48] Decrease in Skeletal Muscle Index After Definitive Chemoradiation Therapy for Stage III Non-small Cell Lung Cancer is Associated With Decreased Overall Survival
    Sen, N.
    Vo, N.
    Fughhi, I.
    Marwaha, G.
    Sher, D. J.
    Fidler, M.
    Batus, M.
    Shah, P.
    Bonomi, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E494 - E495
  • [49] Decreased ERCC1 Expression After Platinum-Based Neoadjuvant Chemotherapy in non-Small Cell Lung Cancer
    Podmaniczky, Eszter
    Fabian, Katalin
    Papay, Judit
    Puskas, Rita
    Gyulai, Marton
    Furak, Jozsef
    Tiszlavicz, Laszlo
    Losonczy, Gyoergy
    Timar, Jozsef
    Moldvay, Judit
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (02) : 423 - 431
  • [50] Patterns of regional failure in stage III non-small cell lung cancer treated with neoadjuvant chemoradiation therapy and resection
    Garg, Shalini
    Gielda, Benjamin T.
    Turian, Julius V.
    Liptay, Michael
    Warren, William H.
    Bonomi, Philip
    Sher, David J.
    PRACTICAL RADIATION ONCOLOGY, 2013, 3 (04) : 287 - 293
12345